Loading clinical trials...
Loading clinical trials...
A Phase II Study Assessing SU-011248 in Previously Untreated Patients With Advanced Urothelial Cancer Ineligible for Cisplatin-Based Chemotherapy
Conditions
Interventions
sunitinib malate
immunohistochemistry staining method
+3 more
Locations
4
Spain
Hospital Del Mar
Barcelona, Spain
Hospital de la Santa Cruz i Sant Pau
Barcelona, Spain
Hospital Universitario San Carlos
Madrid, Spain
Hospital Universitario 12 de Octubre
Madrid, Spain
Start Date
July 1, 2006
Primary Completion Date
December 1, 2010
Last Updated
August 7, 2013
NCT04235764
NCT00026884
NCT07061964
NCT03375307
NCT04585750
NCT07050771
Lead Sponsor
Hospital del Mar
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions